Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study.
Bi P, Wang X, Liu R, Li X, Wei S, Zhao J, Tan X, Zhang F, Mao Q, Zhang Y, Tang B, Xun X, Guo R, Zheng K, Zhou S, Tang S.
Bi P, et al. Among authors: xun x.
Surg Open Sci. 2023 Oct 31;16:171-183. doi: 10.1016/j.sopen.2023.10.008. eCollection 2023 Dec.
Surg Open Sci. 2023.
PMID: 38026829
Free PMC article.